Skip to main content

Advertisement

Log in

Cervical adenocarcinoma associated with persistent human papilloma and human immunodeficiency viral infections

  • Case report
  • Published:
International Cancer Conference Journal Aims and scope Submit manuscript

Abstract

Women infected with the human immunodeficiency virus face a higher risk of developing squamous cell carcinoma of the uterine cervix, but the association with glandular cervical lesions is not well known. A 39-year-old woman infected with human immunodeficiency virus was treated with conization for carcinoma in situ and adenocarcinoma in situ with complete resection. Fourteen years later at the age of 53, the squamous lesions had not progressed, but the glandular lesion developed into cervical adenocarcinoma. Increased risk of squamous cervical lesions in women with human immunodeficiency virus is related to immunosuppression. Local immunosuppression in cervical lesions may interact with persistent human papillomavirus infection. The interplay between human papilloma virus type 18 and local immunosuppression may be associated with development of cervical adenocarcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

References

  1. Bratcher LF, Sahasrabuddhe VV (2010) The impact of antiretroviral therapy on HPV and cervical intraepithelial neoplasia: current evidence and directions for future research. Infect Agent Cancer 5:8

    Article  PubMed Central  PubMed  Google Scholar 

  2. Lodi CT, Michelin MA, Lima MI et al (2011) Factors associated with recurrence of cervical intraepithelial neoplasia after conization in HIV-infected and noninfected women. Arch Gynecol Obstet 284:191–197

    Article  PubMed  Google Scholar 

  3. Lima MI, Tafuri A, Araújo AC et al (2009) Cervical intraepithelial neoplasia recurrence after conization in HIV-positive and HIV-negative women. Int J Gynaecol Obstet 104:100–104

    Article  PubMed  Google Scholar 

  4. Vernon SD, Hart CE, Reeves WC et al (1993) The HIV-1 tat protein enhances E2-dependent human papillomavirus 16 transcription. Virus Res 27:133–145

    Article  CAS  PubMed  Google Scholar 

  5. Tornesello ML, Buonaguro FM, Beth-Giraldo E et al (1993) Human immunodeficiency virus type 1 tat gene enhances human papillomavirus early gene expression. Intervirology 36:57–64

    CAS  PubMed  Google Scholar 

  6. Spinillo A, Tenti P, Zappatore R et al (1993) Langerhans’ cell counts and cervical intraepithelial neoplasia in women with human immunodeficiency virus infection. Gynecol Oncol 48:210–213

    Article  CAS  PubMed  Google Scholar 

  7. Olaitan A, Johnson MA, MacLean A et al (1996) The distribution of immunocompetent cells in the genital tract of HIV-positive women. AIDS 10:759–764

    Article  CAS  PubMed  Google Scholar 

  8. Nicol AF, Pires AR, de Souza SR et al (2008) Cell-cycle and suppressor proteins expression in uterine cervix in HIV/HPV co-infection: comparative study by tissue micro-array (TMA). BMC Cancer 8:289

    Article  PubMed Central  PubMed  Google Scholar 

  9. Dahlström LA, Ylitalo N, Sundström K et al (2010) Prospective study of human papillomavirus and risk of cervical adenocarcinoma. Int J Cancer 127:1923–1930

    Article  PubMed Central  PubMed  Google Scholar 

  10. de Sanjose S, Quint WG, Alemany L et al (2010) Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 11:1048–1056

    Article  PubMed  Google Scholar 

  11. Massad LS, Xie X, Darragh TM et al (2009) Histologic correlates of glandular abnormalities in cervical cytology among women with human immunodeficiency virus. Obstet Gynecol 114:1063–1068

    Article  PubMed Central  PubMed  Google Scholar 

  12. Odida M, Sandin S, Mirembe F et al (2011) HPV types, HIV and invasive cervical carcinoma risk in Kampala, Uganda: a case-control study. Infect Agent Cancer 6:8

    Article  PubMed Central  PubMed  Google Scholar 

  13. Costa S, Venturoli S, Negri G et al (2012) Factors predicting the outcome of conservatively treated adenocarcinoma in situ of the uterine cervix: an analysis of 166 cases. Gynecol Oncol 124:490–495

    Article  PubMed  Google Scholar 

  14. Salani R, Puri I, Bristow RE (2009) Adenocarcinoma in situ of the uterine cervix: a metaanalysis of 1278 patients evaluating the predictive value of conization margin status. Am J Obstet Gynecol 200:182.e1–182.e5

    Google Scholar 

Download references

Acknowledgments

We thank Yoshiaki Imamura, MD, whose comments and suggestions regarding cervical adenocarcinoma, particularly for diagnosis, were invaluable. The authors also thank the patient for permission to report her case.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hideaki Tsuyoshi.

About this article

Cite this article

Tsuyoshi, H., Shinagawa, A., Kurokawa, T. et al. Cervical adenocarcinoma associated with persistent human papilloma and human immunodeficiency viral infections. Int Canc Conf J 3, 195–199 (2014). https://doi.org/10.1007/s13691-013-0147-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13691-013-0147-1

Keywords

Navigation